Corinne Vigouroux

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 129 publications

European Consortium for Lipodystrophies consensus definition and classification framework for monogenic lipodystrophy.

European Consortium for Lipodystrophies consensus definition and classification framework for monogenic lipodystrophy.

Journal: Journal of internal medicine

Published: September 02, 2026

The risk of nephrotic range proteinuria and kidney failure in primary laminopathies is genotype-specific.

The risk of nephrotic range proteinuria and kidney failure in primary laminopathies is genotype-specific.

Journal: JCI insight

Published: July 16, 2026

Corrigendum to 'Pink adipose tissue: A paradigm of adipose tissue plasticity' [Ann. Endocrinol. 85 (2004) 248-51].

Corrigendum to 'Pink adipose tissue: A paradigm of adipose tissue plasticity' [Ann. Endocrinol. 85 (2004) 248-51].

Journal: Annales d'endocrinologie

Published: June 30, 2026

Comment on Korakas et al. 780G Hybrid Closed-Loop Pump as Adjunct to Metreleptin in Lipodystrophy-Associated Diabetes: Three Case Observations.

Comment on Korakas et al. 780G Hybrid Closed-Loop Pump as Adjunct to Metreleptin in Lipodystrophy-Associated Diabetes: Three Case Observations.

Journal: Diabetes care

Published: June 22, 2026

Genomic newborn screening as a paradigm shift in rare disease management, with emphasis on endocrine conditions.

Genomic newborn screening as a paradigm shift in rare disease management, with emphasis on endocrine conditions.

Journal: Annales d'endocrinologie

Published: May 08, 2026

Glycemic and Renal Effects of SGLT2 Inhibitors in Monogenic Diabetes: A Real-World National Study.

Glycemic and Renal Effects of SGLT2 Inhibitors in Monogenic Diabetes: A Real-World National Study.

Journal: Diabetes, obesity & metabolism

Published: April 27, 2026

Efficacy and Safety of SGLT2 Inhibitors in Patients With Genetic Lipodystrophy: A Real-Life Experience From a National Reference Network.

Efficacy and Safety of SGLT2 Inhibitors in Patients With Genetic Lipodystrophy: A Real-Life Experience From a National Reference Network.

Journal: Diabetes, obesity & metabolism

Published: April 09, 2026

Genomic newborn screening as a paradigm shift in rare disease management, with emphasis on endocrine conditions.

Genomic newborn screening as a paradigm shift in rare disease management, with emphasis on endocrine conditions.

Journal: Annales d'endocrinologie

Published: March 21, 2026

Maturity Onset Diabetes of the Young (MODY): French National Diagnosis and Care Protocol (PNDS, Protocole National de Diagnostic et de Soins).

Maturity Onset Diabetes of the Young (MODY): French National Diagnosis and Care Protocol (PNDS, Protocole National de Diagnostic et de Soins).

Journal: Orphanet journal of rare diseases

Published: October 29, 2025

Increased epicardial adipose tissue is part of the phenotype of LMNA-associated partial lipodystrophy and could contribute to increased cardiovascular risk.

Increased epicardial adipose tissue is part of the phenotype of LMNA-associated partial lipodystrophy and could contribute to increased cardiovascular risk.

Journal: Diabetes & metabolism

Published: September 16, 2025

Epidemiological and clinical data from the European Lipodystrophy Registry.

Epidemiological and clinical data from the European Lipodystrophy Registry.

Journal: European journal of endocrinology

Published: August 02, 2025

Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip) Paris, France, 20-21 May 2025.

Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip) Paris, France, 20-21 May 2025.

Journal: Annales d'endocrinologie

Published: August 01, 2025

Showing 1-12 of 129

Last Updated: 09/26/2026